Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy-Reference-Cited by-同舟云学术

Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy

Published:2008-03 Issue:3 Volume:18 Page:333-346
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Bartalena Luigi¹,Baldeschi Lelio²,Dickinson Alison J.³,Eckstein Anja⁴,Kendall-Taylor Pat⁵,Marcocci Claudio⁶,Mourits Maarten P.⁷,Perros Petros⁸,Boboridis Kostas⁹,Boschi Antonella¹⁰,Currò Nicola¹¹,Daumerie Chantal¹²,Kahaly George J.¹³,Krassas Gerasimos¹⁴,Lane Carol M.¹⁵,Lazarus John H.¹⁶,Marinò Michele⁶,Nardi Marco¹⁷,Neoh Christopher³,Orgiazzi Jacques¹⁸,Pearce Simon¹⁹,Pinchera Aldo⁶,Pitz Susanne²⁰,Salvi Mario²¹,Sivelli Paolo²²,Stahl Matthias²³,von Arx Georg²⁴,Wiersinga Wilmar M.²⁵

Affiliation:

1. Department of Clinical Medicine, University of Insubria, Varese, Italy.

2. Department of Ophthalmology, Academic Medical Center, Amsterdam, the Netherlands.

3. Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.

4. Department of Ophthalmology, University of Essen, Essen, Germany.

5. Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

6. Department of Endocrinology, University of Pisa, Pisa, Italy.

7. Orbital Center, Department of Ophthalmology, Academic Medical Center, Amsterdam, the Netherlands.

8. Department of Endocrinology, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

9. University Department of Ophthalmology, Ahepa Hospital, Thessaloniki, Greece.

10. Department of Ophthalmology, Université Catholique de Louvain, Cliniques Universitaires, Brussels, Belgium.

11. Department of Ophthalmology, University of Milan, Milan, Italy.

12. Université Catholique de Louvain, Cliniques Universitaires, Brussels, Belgium.

13. Department of Medicine I, Gutenberg University Hospital, Mainz, Germany.

14. Department of Endocrinology, Panagia General Hospital, Thessaloniki, Greece.

15. Cardiff Eye Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

16. School of Medicine, Cardiff University, Llandough Hospital, Cardiff, United Kingdom.

17. Department of Neuroscience, Section of Ophthalmology, University of Pisa, Pisa, Italy.

18. Department of Endocrinology, Centre Hospitalier Lyon-Sud, Lyon, France.

19. School of Clinical Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.

20. Department of Ophthalmology, Johannes Gutenberg-University, Mainz, Germany.

21. Department of Medical Sciences, University of Milan, Milan, Italy.

22. Department of Ophthalmology, University of Insubria, Varese, Italy.

23. Department of Endocrinology, Solothurner Spitaler, Switzerland.

24. Interdisziplinares Zentrum fur Endokrine Orbitopathie, Olten, Switzerland.

25. Department of Endocrinology, Academic Medical Center, Amsterdam, the Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2007.0315

Reference93 articles.

1. Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers

2. A questionnaire survey on the management of Graves’ orbitopathy in Europe

3. Management of Graves' Ophthalmopathy: Reality and Perspectives

4. Graves' Disease

5. Pathogenesis of Graves' Ophthalmopathy--Current Understanding

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evaluation of retrobulbar fat tissue in Graves’ orbitopathy with shear-wave ultrasound elastography;International Ophthalmology;2024-02-06

2. Evaluation of lamina cribrosa and peripapillary vascular density in thyroid orbitopathy and effect of intravenous methylprednisolone therapy;Canadian Journal of Ophthalmology;2023-12

3. Prevalence, Incidence, and Clinical Characteristics of Thyroid Eye Disease in Japan;Journal of the Endocrine Society;2023-11-27

4. Teprotumumab and Orbital Decompression for the Management of Proptosis in Patients With Thyroid Eye Disease;Ophthalmic Plastic & Reconstructive Surgery;2023-11-16

5. Elevated serum thyroid stimulating immunoglobulin linked to failure of first-line intravenous methylprednisolone monotherapy in moderate-to-severe thyroid eye disease;Eye;2023-10-11